Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
303.50    0.00 (0.00%)
Bid:
303.50
Ask:
304.00
Spread: 0.50 (0.165%)
Market Cap: £179.17m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Director/PDMR Shareholding

18 May 2018 11:13

RNS Number : 5808O
Treatt PLC
18 May 2018
 

18 May 2018

TREATT PLC

("Treatt" or "the Company")

Notification of Transactions of Directors

In accordance with the requirements of the EU Market Abuse Regulation, the Company received notification by certain Directors on 17 May 2018 of the following transactions.

 

Awards granted pursuant to the 2014 Long Term Incentive Plan ("2014 LTIP) to Daemmon Reeve, Chief Executive Officer, and Richard Hope, Chief Financial Officer, in 2014 and vested in full on 15 December 2017, were subject to performance criteria based upon the average annual growth in pre-exceptional basic earnings per share over a three-year period.

Awards granted pursuant to an Unapproved Share Option, which was granted to Daemmon Reeve in 2012 and vested in full on 14 December 2017, was also subject to performance criteria based upon the average annual growth in pre-exceptional basic earnings per share over a five-year period.

Restricted Stock Units (RSUs) were granted to Daemmon Reeve in 2014 pursuant to an all staff award for eligible US employees, which were granted on terms consistent with awards made to UK employees under the Treatt Plc Share Incentive Plan.

These vestings and exercises are detailed below, including the number of Ordinary Shares each sold at a price of 486 pence per share to satisfy the tax and national insurance liabilities and administrative fees arising on exercise:

Ordinary Shares received pursuant to 2014 LTIP

Ordinary Shares received pursuant to Unapproved Share Option Scheme

Ordinary Shares received pursuant to Restricted Stock Units

Ordinary Shares sold

Resultant interest in Ordinary Shares

Resultant % holding in total issued share capital

Daemmon Reeve

CEO

164,816

78,195

366

105,868

302,861

0.52%

Richard Hope

CFO

128,400

-

-

60,348

286,451

0.49%

 

Further details regarding the 2014 LTIP, the Unapproved Share Option and the Restricted Stock Units are set out in the Company's 2017 Annual Report.

 

Contact details

Anita Steer

Company Secretary

++ 44 1284 770028

 

 

Details of the Director

a)

 

 

Name

1. Daemmon Reeve

2. Richard Hope

2

Reason for the notification

a)

 

 

Position/status

1. CEO

2. CFO

b)

Initial notification/Amendment

 Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Treatt Plc

b)

LEI

 213800G40JM9F7G9LG39

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b)

Nature of transaction

1. Only:

a) Exercise of 2014 LTIP

b) Exercise of 2012 Unapproved Share Option

c) Exercise of All Staff RSUs

d) Sale of shares to satisfy UK & US tax liabilities and subscription for 2012 Unapproved Share Option

2. Only:

e) Exercise of 2014 LTIP

f) Sale of shares to satisfy tax UK liabilities

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1a) nil cost

1b) £0.79

1c) nil cost

1d) £4.86

 

2a) nil cost

2b) £4.86

164,816

78,195

366

105,868

 

128,400

60,348

Aggregated information

- Aggregated volume

- Price

 

N/A (Single transaction)

e)

Date of the transaction

17 May 2018

f)

Place of the transaction

London Stock Exchange, XLON

 

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBGGDUCGBBGII
Date   Source Headline
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20259:07 amRNSHolding(s) in Company
10th Apr 20257:01 amRNSShare Buyback Programme
10th Apr 20257:00 amRNSTrading Update
25th Mar 202511:30 amRNSVoting Rights and Capital
24th Mar 20257:00 amRNSDirectorate Change
19th Mar 20253:33 pmRNSDirector/PDMR Shareholding
6th Feb 20254:18 pmRNSHolding(s) in Company
4th Feb 202511:55 amRNSHolding(s) in Company
30th Jan 20254:17 pmRNSResult of AGM
30th Jan 20257:00 amRNSAGM Trading Update
20th Dec 202411:24 amRNSNotification of Transactions of Directors
17th Dec 20244:07 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20241:44 pmRNSNotification of Transactions of Directors
4th Dec 20241:47 pmRNS2024 Final Dividend
4th Dec 20247:00 amRNSFull Year Results
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
15th Nov 20247:00 amRNSBoard Change
16th Oct 202412:00 pmRNSChange in Director's Duties
10th Oct 20247:00 amRNSTrading Update
24th Sep 20242:06 pmRNSDirector/PDMR Shareholding
20th Aug 202411:06 amRNSNotification of Transactions of Directors
12th Jul 202410:49 amRNSDirector/PDMR Shareholding
4th Jun 202410:35 amRNSBlock Listing Six Monthly Return
4th Jun 202410:25 amRNSBlock Listing Six Monthly Return
3rd Jun 20247:00 amRNSDavid Shannon joins as CEO
14th May 20247:00 amRNSHalf Year Results
30th Apr 20244:02 pmRNSVoting Rights and Capital
10th Apr 20247:00 amRNSHalf Year Trading Update & Notice of Results
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting
1st Dec 20237:01 amRNSBlock Listing Six Monthly Return
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
28th Nov 20234:15 pmRNS2023 Final Dividend
28th Nov 20237:00 amRNSFull Year Results
20th Oct 20237:00 amRNSCEO Succession
10th Oct 20237:00 amRNSTrading Update
18th Sep 20234:11 pmRNSHolding(s) in Company
15th Aug 20234:14 pmRNSNotification of Transactions of Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.